Systematic investigation of genetically determined plasma and urinary metabolites to discover potential interventional targets for colorectal cancer

We aimed to identify plasma and urinary metabolites related to colorectal cancer (CRC) risk and elucidate their mediator role in the associations between modifiable risk factors and CRC.